| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-80807-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-87945-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-03232-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-84437-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76566-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59472-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB600-212SS | |||
![Western Blot: Hornerin Antibody [NBP1-80807] - Hornerin expression in HCC cell lines. Western blot analysis of Hornerin expression levels in a panel of HCC cell lines. Image collected and cropped by CiteAb from the following publication (//bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4719-5), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Western-Blot-NBP1-80807-img0013.jpg "Western Blot: Hornerin Antibody [NBP1-80807] - Hornerin expression in HCC cell lines. Western blot analysis of Hornerin expression levels in a panel of HCC cell lines. Image collected and cropped by CiteAb from the following publication (//bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4719-5), licensed under a CC-BY license.")
![Immunohistochemistry: Hornerin Antibody [NBP1-80807] - Hornerin overpression in human HCC tumor tissues. Immunohistochemistry of Hornerin expression in hepatocellular carcinoma (HCC) tissues. Hornerin expression in the cytoplasm and membrane is scored as negative (a, e), weak (b, f), moderate (c, g), and strong (d, h). Original magnification, x 100 (a-d); x 400 (e-h) Image collected and cropped by CiteAb from the following publication (//bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4719-5), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Immunohistochemistry-NBP1-80807-img0011.jpg)
![Immunohistochemistry-Paraffin: Hornerin Antibody [NBP1-80807] - Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Immunohistochemistry-Paraffin-NBP1-80807-img0007.jpg)
![Immunohistochemistry-Paraffin: Hornerin Antibody [NBP1-80807] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Immunohistochemistry-Paraffin-NBP1-80807-img0008.jpg)
![Immunohistochemistry-Paraffin: Hornerin Antibody [NBP1-80807] - Staining of human skin shows moderate to strong cytoplasmic granular positivity in the cornified layer.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Immunohistochemistry-Paraffin-NBP1-80807-img0009.jpg)
![Immunohistochemistry-Paraffin: Hornerin Antibody [NBP1-80807] - Staining of human testis shows weak positivity in peritubular myoid cells.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Immunohistochemistry-Paraffin-NBP1-80807-img0010.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: Hornerin Antibody [NBP1-80807] - Hornerin expression in HCC cell lines. RNR shRNAs inhibited the expression of Hornerin in PLC/PRF/5 and QGY-7703 cells Image collected and cropped by CiteAb from the following publication (//bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4719-5), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Hornerin-Antibody-Knockdown-Validated-NBP1-80807-img0012.jpg)
![Western Blot: ELF3/ESE-1 Antibody [NBP1-30873] - Loss of Elf3 preserves the mesenchymal state. Immunoblot showing ELF3 and E-cadherin protein levels in response to Elf3 silencing by siRNAs. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/2073-4409/8/8/858) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Western-Blot-NBP1-30873-img0010.jpg "Western Blot: ELF3/ESE-1 Antibody [NBP1-30873] - Loss of Elf3 preserves the mesenchymal state. Immunoblot showing ELF3 and E-cadherin protein levels in response to Elf3 silencing by siRNAs. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/2073-4409/8/8/858) licensed under a CC-BY license.")
![Immunocytochemistry/Immunofluorescence: ELF3/ESE-1 Antibody [NBP1-30873] - Methanol-fixed HeLa, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-30873-img0006.jpg)
![Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-30873] - Human lung carcinoma. ESE1 antibody [C2C3], C-term diluted at 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-30873-img0009.jpg)
![Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-30873] - NCI-N87 xenograft, using ESE1 antibody at 1:100 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-30873-img0007.jpg)
![Chromatin Immunoprecipitation: ELF3/ESE-1 Antibody [NBP1-30873] - The transcription factor ELF3 regulates the Grhl3 promoter. (A) The sequence of the Grhl3 promoter (1000 bp) showing the location of the predicted TATA box, SP1 sequence, & the transcription start site. Sequences in red represent the conserved regions, & green bases represent putative ELF3 binding sites. (B) Luciferase reporter assay showing the activation of the Grhl3 promoter by ELF3. Relative luciferase activity is calculated as fold induction relative to vector. Drawings on the left side show a schematic representation of the Grhl3 promoter region (top) & the structure of each reporter plasmid (below). The conserved regions are shown as horizontal boxes labeled 1,2 & 3, the restriction enzymes used to generate the reporter deletions of the promoter are labeled. (C) ELF3 binding at the promoter of Grhl3. NMuMG cells were treated with either vehicle or TGF beta 3 for 72 h, TGF beta 3 treated cells were then washed with PBS & continued incubation for an additional 48 h to initiate MET (post-treatment: PT48). Cells were cross-linked, & chromatin immunoprecipitation was performed. ChIP DNA was used in qPCR to measure the occupancy of ELF3 compared to control antibodies. (D) Sequence alignment of one putative ELF3 binding site in the Grhl3 promoter showing conservation among different species. In B & C, data represent the averages of at least three independent experiments. The paired Student’s t-test was used to calculate statistical significance. ** p-value < 0.01; **** p-value < 0.0001. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31404945), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-30873_rabbit-polyclonal-elf3-ese-1-antibody-310202416182629.jpg)
![<b>Orthogonal Strategies Validation. </b>Western Blot: ELF3/ESE-1 Antibody [NBP1-30873] - Various whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with ESE1 antibody [C2C3], C-term diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.](http://images.novusbio.com/fullsize/nbp1-30873_rabbit-polyclonal-elf3-ese-1-antibody-161020241941455.jpg)
![Western Blot: ELF3/ESE-1 Antibody [NBP1-87945] - Analysis in human cell lines A-431 and SK-MEL-30 using anti-ELF3 antibody. Corresponding ELF3 RNA-seq data are presented for the same cell lines. Loading control: anti-PPIB.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Western-Blot-NBP1-87945-img0012.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: ELF3/ESE-1 Antibody [NBP1-87945] - Analysis in human cell lines A-431 and SK-MEL-30 using anti-ELF3 antibody. Corresponding ELF3 RNA-seq data are presented for the same cell lines. Loading control: anti-PPIB.")
![Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-87945] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-87945-img0016.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-87945] - Staining of human colon, endometrium, pancreas and skeletal muscle using Anti-ELF3/ESE-1 antibody NBP1-87945 (A) shows similar protein distribution across tissues to independent antibody NBP1-87946 (B).](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-87945-img0019.jpg)
![Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-87945] - Staining of human pancreas shows moderate nuclear positivity in pancreatic ducts.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-87945-img0008.jpg)
![Immunohistochemistry-Paraffin: ELF3/ESE-1 Antibody [NBP1-87945] - Staining of human endometrium shows moderate to strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-Immunohistochemistry-Paraffin-NBP1-87945-img0018.jpg)
![Immunocytochemistry/Immunofluorescence: S100A11 Antibody (2F4) [H00006282-M01] - Analysis of monoclonal antibody to S100A11 on HeLa cell . Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/S100A11-Antibody-2F4-Immunocytochemistry-Immunofluorescence-H00006282-M01-img0004.jpg "Immunocytochemistry/Immunofluorescence: S100A11 Antibody (2F4) [H00006282-M01] - Analysis of monoclonal antibody to S100A11 on HeLa cell . Antibody concentration 10 ug/ml.")
![Immunohistochemistry-Paraffin: S100A11 Antibody (2F4) [H00006282-M01] - Analysis of monoclonal antibody to S100A11 on formalin-fixed paraffin-embedded human placenta. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/S100A11-Antibody-2F4-Immunohistochemistry-Paraffin-H00006282-M01-img0006.jpg)
![Sandwich ELISA: S100A11 Antibody (2F4) [H00006282-M01] - Detection limit for recombinant GST tagged S100A11 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/S100A11-Antibody-2F4-Sandwich-ELISA-H00006282-M01-img0007.jpg)
![Western Blot: S100A11 Antibody [NBP1-32998] - Wild-type (WT) and S100A11 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with S100A11 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/S100A11-Antibody-Western-Blot-NBP1-32998-img0006.jpg "<b>Genetic Strategies Validation. </b>Western Blot: S100A11 Antibody [NBP1-32998] - Wild-type (WT) and S100A11 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with S100A11 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: S100A11 Antibody [NBP1-32998] - Analysis of paraformaldehyde-fixed HeLa, using NBP1-32998.](http://images.novusbio.com/fullsize/S100A11-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32998-img0002.jpg)
![Immunohistochemistry-Paraffin: S100A11 Antibody [NBP1-32998] - Paraffin-embedded SW480 Xenograft, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/S100A11-Antibody-Immunohistochemistry-Paraffin-NBP1-32998-img0004.jpg)
![Western Blot: ELF3/ESE-1 Antibody (7O2V4) [NBP3-16429] - Western blot analysis of extracts of various cell lines, using ELF3/ESE-1 Rabbit mAb (NBP3-16429) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/ELF3-ESE-1-Antibody-7O2V4-Western-Blot-NBP3-16429-img0001.jpg "Western Blot: ELF3/ESE-1 Antibody (7O2V4) [NBP3-16429] - Western blot analysis of extracts of various cell lines, using ELF3/ESE-1 Rabbit mAb (NBP3-16429) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Chromatin Immunoprecipitation: ELF3/ESE-1 Antibody (7O2V4) [NBP3-16429] - Analysis of extracts of HepG2 cells, using ESE1/ELF3 antibody and rabbit IgG.The amount of immunoprecipitated DNA was checked by quantitative PCR. Histogram was constructed by the ratios of the immunoprecipitated DNA to the input.](http://images.novusbio.com/fullsize/nbp3-16429_rabbit-elf3-ese-1-mab-7o2v4-chromatin-immunoprecipitation-chip--2492024124532..jpg)
![Chip IP Sequencing: ELF3/ESE-1 Antibody (7O2V4) [NBP3-16429] -CUT&Tag was performed using the CUT&Tag Assay Kit (pAG-Tn5) for Illumina from 10⁵ HepG5 with 1μg ESE1 along with a Goat Anti-Rabbit IgG(H+L). The CUT&Tag results indicate the enrichment pattern of ESE1 in representative gene loci (MARK4), as shown in figure.](http://images.novusbio.com/fullsize/nbp3-16429_rabbit-elf3-ese-1-mab-7o2v4-chromatin-immunoprecipitation-sequencing-2492024131643..jpg)
![Chromatin Immunoprecipitation: ELF3/ESE-1 Antibody (7O2V4) [NBP3-16429] - Chromatin immunoprecipitation analysis of extracts of HepG2 cells, using ELF3/ESE-1 antibody and rabbit IgG.The amount of immunoprecipitated DNA was checked by quantitative PCR. Histogram was constructed by the ratios of the immunoprecipitated DNA to the input.](http://images.novusbio.com/fullsize/nbp3-16429_rabbit-elf3-ese-1-mab-7o2v4-52202511374128.jpg)
![Chromatin Immunoprecipitation: ELF3/ESE-1 Antibody (7O2V4) [ELF3/ESE-1] - Chromatin immunoprecipitation analysis of extracts of HepG2 cells, using ELF3/ESE-1 antibody and rabbit IgG.The amount of immunoprecipitated DNA was checked by quantitative PCR. Histogram was constructed by the ratios of the immunoprecipitated DNA to the input.](http://images.novusbio.com/fullsize/nbp3-16429_rabbit-elf3-ese-1-mab-7o2v4-52202517213584.jpg)
![Western Blot: S100A11 Antibody [NBP3-03232] - Analysis of extracts of various cell lines, using S100A11 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit.](http://images.novusbio.com/fullsize/S100A11-Antibody-Western-Blot-NBP3-03232-img0004.jpg "Western Blot: S100A11 Antibody [NBP3-03232] - Analysis of extracts of various cell lines, using S100A11 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit.")
![Immunocytochemistry/Immunofluorescence: S100A11 Antibody [NBP3-03232] - Analysis of U2OS cells using S100A11 antibody . Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/S100A11-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-03232-img0001.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: S100A11 Antibody [NBP3-03232] - Analysis of extracts from normal (control) and S100A11 knockout (KO) HeLa cells, using S100A11 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/S100A11-Antibody-Knockout-Validated-NBP3-03232-img0003.jpg)
![Immunoprecipitation: S100A11 Antibody [NBP3-03232] - Immunoprecipitation analysis of 200ug extracts of THP-1 cells using 3ug S100A11 antibody (NBP3-03232). Western blot was performed from the immunoprecipitate using S100A11 antibody (NBP3-03232) at a dilution of 1:1000.](http://images.novusbio.com/fullsize/S100A11-Antibody-Immunoprecipitation-NBP3-03232-img0005.jpg)
![Immunohistochemistry-Paraffin: CALML5 Antibody [NBP1-84437] - Staining in human skin and skeletal muscle tissues using anti-CALML5 antibody. Corresponding CALML5 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CALML5-Antibody-Immunohistochemistry-Paraffin-NBP1-84437-img0008.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CALML5 Antibody [NBP1-84437] - Staining in human skin and skeletal muscle tissues using anti-CALML5 antibody. Corresponding CALML5 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: CALML5 Antibody [NBP1-84437] - Immunofluorescent staining of human cell line A-431 shows localization to plasma membrane & cytosol.](http://images.novusbio.com/fullsize/CALML5-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-84437-img0006.jpg)
![Immunohistochemistry-Paraffin: CALML5 Antibody [NBP1-84437] - Staining of human skeletal muscle shows low expression as expected.](http://images.novusbio.com/fullsize/CALML5-Antibody-Immunohistochemistry-Paraffin-NBP1-84437-img0007.jpg)
![Western Blot: ATP2C1 Antibody [NBP1-76566] - mouse brain tissue lysate with ATP2C1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/ATP2C1-Antibody-Western-Blot-NBP1-76566-img0001.jpg "Western Blot: ATP2C1 Antibody [NBP1-76566] - mouse brain tissue lysate with ATP2C1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: ATP2C1 Antibody - BSA Free [NBP1-76566] - Immunofluorescence of ATP2C1 in mouse brain tissue with ATP2C1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76566_rabbit-polyclonal-atp2c1-antibody-271120241933342.jpg)
![Immunohistochemistry: ATP2C1 Antibody - BSA Free [NBP1-76566] - Immunohistochemistry of ATP2C1 in mouse brain tissue with ATP2C1 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76566_rabbit-polyclonal-atp2c1-antibody-271120242004129.jpg)
![Western Blot: S100A11 Antibody (20D11) - BSA Free [NBP2-59472] - Lane 1: HeLa cell lysates, Lane 2: MCF7 cell lysates, Lane 3: PC3 cell lysates, Lane 4: HaCaT cell lysates, Lane 5: THP1 cell lysates, Lane 6: U87MG cell lysates, Lane 7: A427 cell lysates, Lane 8: SK-OV-3 cell lysates, Lane 9: A549 cell lysates](http://images.novusbio.com/fullsize/S100A11-Antibody-20D11-BSA-Free-Western-Blot-NBP2-59472-img0001.jpg "Western Blot: S100A11 Antibody (20D11) - BSA Free [NBP2-59472] - Lane 1: HeLa cell lysates, Lane 2: MCF7 cell lysates, Lane 3: PC3 cell lysates, Lane 4: HaCaT cell lysates, Lane 5: THP1 cell lysates, Lane 6: U87MG cell lysates, Lane 7: A427 cell lysates, Lane 8: SK-OV-3 cell lysates, Lane 9: A549 cell lysates")
![Immunocytochemistry/Immunofluorescence: S100A11 Antibody (20D11) - BSA Free [NBP2-59472] - Analysis of S100A11 in A549 cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human S100A11 antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).](http://images.novusbio.com/fullsize/S100A11-Antibody-20D11-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-59472-img0002.jpg)
![Flow Cytometry: S100A11 Antibody (20D11) - BSA Free [NBP2-59472] - Flow cytometry analysis of S100A11 in HeLa cells. The cell was stained with NBP2-59472 at 2-5ug for 1x10^6cells (red). A Goat anti mouse IgG (Alexa fluor 488) was used as the secondary antibody. Mouse monoclonal IgG was used as the isotype control (dark gray), cells without incubation with primary and secondary antibody was used as the negative control (light gray).](http://images.novusbio.com/fullsize/S100A11-Antibody-20D11-BSA-Free-Flow-Cytometry-NBP2-59472-img0005.jpg)
![ELISA: S100A11 Antibody (20D11) - BSA Free [NBP2-59472] - Flow cytometry analysis of S100A11 in A549 cells. The cell was stained with NBP2-59472 at 2-5ug for 1x10^6cells (red). A Goat anti mouse IgG (Alexa fluor 488) was used as the secondary antibody. Mouse monoclonal IgG was used as the isotype control (dark gray), cells without incubation with primary and secondary antibody was used as the negative control (light gray).](http://images.novusbio.com/fullsize/S100A11-Antibody-20D11-BSA-Free-ELISA-NBP2-59472-img0006.jpg)
![Western Blot: ATP2C1 Antibody (4G12) [NBP1-47467] - Western blot analysis using ATP2C1 mouse mAb against human recombinant ATP2C1.](http://images.novusbio.com/fullsize/ATP2C1-Antibody-4G12-Western-Blot-NBP1-47467-img0003.jpg "Western Blot: ATP2C1 Antibody (4G12) [NBP1-47467] - Western blot analysis using ATP2C1 mouse mAb against human recombinant ATP2C1.")
![Immunohistochemistry: ATP2C1 Antibody (4G12) [NBP1-47467] - Immunohistochemical analysis of paraffin-embedded human ovarian cancer (left) and breast cancer (right) tissues using ATP2C1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/ATP2C1-Antibody-4G12-Immunohistochemistry-NBP1-47467-img0001.jpg)
![Western Blot: ATP2C1 Antibody (4G12) [NBP1-47467] - Western blot analysis using ATP2C1 mouse mAb against A431 (1), Hela (2) and HEK293 (3) cell lysate.](http://images.novusbio.com/fullsize/ATP2C1-Antibody-4G12-Western-Blot-NBP1-47467-img0002.jpg)
![Western Blot: ESE1 Antibody [NB600-212] - WB detection of ESE1 in T84 colon carcinoma cells with NB600-212 antibody at a dilution of 1:500. Please note that this antibody detects both isoforms of ESE1 with expected molecular weight of 41.4 kDa and 39.3 kDa.](http://images.novusbio.com/fullsize/ESE1-Antibody-Western-Blot-NB600-212-img0001.jpg "Western Blot: ESE1 Antibody [NB600-212] - WB detection of ESE1 in T84 colon carcinoma cells with NB600-212 antibody at a dilution of 1:500. Please note that this antibody detects both isoforms of ESE1 with expected molecular weight of 41.4 kDa and 39.3 kDa.")
![Western Blot: ESE1 Antibody [NB600-212] - Western blot analysis of ESE1 in T84 colon carcinoma cells using NB600-212 at 1:500 dilution. Recognizes both isoforms of ESE1.](http://images.novusbio.com/fullsize/ESE1-Antibody-Western-Blot-NB600-212-img0002.jpg)